Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends higher as Fed holds key rate steady, focus turns to earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1288.30 +6.39 (0.50%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1281.91 | 52 Week High | $88.16 | |||
| Open | $1268.55 | 52 Week Low | $67.88 | |||
| Day High | $1299.43 | P/E | 298.22 | |||
| Day Low | $1260.34 | EPS | $4.32 | |||
| Volume | 2,056,521 | |||||
